Abbott, the US healthcare company, has racked up $10bn of M&A deals in two months with the sale of its core laboratory diagnostics business to conglomerate GE.

Abbott said it will sell its the business included in the Abbott Diagnostics Division and Abbott Point of Care for $8.1bn (€6.2bn) in cash, resulting in after-tax proceeds of $6bn.